Article Details
Retrieved on: 2024-07-04 13:38:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca obtained full oncology rights to monalizumab in October 2018 through a co-development and commercialization agreement initiated in 2015.
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here